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Introduction
============

Ocular involvement in sarcoidosis is common; a recent 2010 consensus study (International Workshop on Ocular Sarcoidosis or IWOS) estimated that 30-60% of sarcoid patients eventually develop ophthalmic disease \[[@REF1]\]. Presentation of sarcoid eye disease can vary, with anterior uveitis being the most common manifestation \[[@REF2]\]. Furthermore, the 2010 IWOS study listed the seven signs of intraocular inflammation most suggestive of ocular sarcoidosis: Mutton-fat/granulomatous keratic precipitates (KPs), trabecular meshwork nodules/tent-shaped peripheral anterior synechiae (PAS), snowballs/string-of-pearls vitreous opacities, multiple chorioretinal peripheral lesions (active/atrophic), nodular/segmented periphlebitis (± candle-wax drippings) /retinal macroaneurysms, optic disc nodules/granulomas/solitary choroidal nodule, and bilaterality \[[@REF1]\]. 

In this report, we present a case of ocular sarcoidosis in a 59-year-old Caucasian male who presented solely as retinal neovascularization and retinal vascular ischemia.

Case presentation
=================

A 59-year-old white male presented with blurry vision of several months duration. His medical history was significant for hypothyroidism and a remote history of thrombophlebitis of his lower extremities and degenerative joint disease. He had a past history of smoking and no history of diabetes mellitus or hypertension. On examination, visual acuity was 20/80 in the right eye and 20/60 in the left eye. The pupillary examination was normal with no afferent pupillary defect, and the anterior segment exam was significant only for moderate nuclear sclerosis in both eyes. Intraocular pressures were within normal limits in both eyes.

In the right eye, venous-venous and arteriovenous collaterals were noted in the temporal macula (Figure [1a](#FIG1){ref-type="fig"}). Funduscopic examination revealed bilateral posterior segment neovascularization, worse in the left eye (Figure [1b](#FIG1){ref-type="fig"}). Mild foveal pigmentary changes were noted in both eyes. The retinal periphery was otherwise normal, and no other lesions were noted. 

Figure 1Red-Free Fundus Photography of Both Eyes on Initial PresentationVenous-venous and arteriovenous collaterals are noted in the temporal macula in the right eye (Figure [1a](#FIG1){ref-type="fig"}). Both eyes demonstrate bilateral posterior segment neovascularization, though worse in the left eye (Figure [1b](#FIG1){ref-type="fig"}).

Fluorescein angiography confirmed the presence of neovascularization bilaterally with enlarged foveal capillary avascular zones, extending into the temporal macula in the right eye (Figure [2a](#FIG2){ref-type="fig"}). Loss of the retinal capillaries and presence of telangiectatic vessels were noted in both fundi (Figure [2a](#FIG2){ref-type="fig"} & Figure [2b](#FIG2){ref-type="fig"}). Vascular inflammatory findings were absent in both eyes.

Figure 2Fluorescein Angiography of Both Eyes on Initial PresentationFluorescein angiography on presentation confirmed the presence of neovascularization bilaterally with enlarged foveal capillary avascular zones and telengiectatic vessels in both eyes (Figure [2a](#FIG2){ref-type="fig"} and Figure [2b](#FIG2){ref-type="fig"}). Figure [2a](#FIG2){ref-type="fig"} (right eye) was taken in the late phase, and Figure [2b](#FIG2){ref-type="fig"} (left eye) was taken in the early venous phase.

A laboratory investigation was obtained which included a serum fluorescent treponemal antibody absorption (FTA-ABS), rapid plasma reagin (RPR), antinuclear antibody (ANA), lysozyme level, angiotensin converting enzyme (ACE) level, and coagulopathy work up; all of which were within normal limits. The patient tested negative for hepatitis C and human immunodeficiency virus (HIV). A transesophageal echocardiogram was negative for thrombi and was significant only for moderate pulmonary hypertension, moderate aortic regurgitation, and a small pericardial effusion.  Carotid ultrasonography at this time demonstrated no significant stenosis or thrombi.

At six-months post-presentation, the patient underwent panretinal photocoagulation in both eyes for new onset bilateral vitreous hemorrhage. At 16-months post-presentation, he required cataract surgery in his left eye; at 19-months, he underwent a pars plana vitrectomy and additional endolaser panretinal photocoagulation for a non-clearing vitreous hemorrhage in his left eye. At no time did the patient present with signs of uveitis or vasculitis.

At 25-months final follow-up, his vision tested at 20/60 in the left eye and 20/100 in the right eye. At this time, funduscopic examination of the right eye demonstrated worsening posterior segment neovascularization. The arteriovenous collaterals and temporal macular vascular pruning had become more prominent. Examination of the left eye demonstrated regression of neovascularization, marked attenuation and sclerosis of the retinal arterial vasculature, and venous-venous collaterals (Figure [3a](#FIG3){ref-type="fig"} & Figure [3b](#FIG3){ref-type="fig"}).

Figure 3Red-Free Fundus Photography of Both Eyes 25 Months after PresentationRed-free images 25 months after presentation demonstrate worsening posterior segment neovascularization despite panretinal photocoagulation. Mature arteriovenous collaterals are noted traversing large areas of capillary dropout and vascular pruning in the temporal macular in the right eye (Figure [3a](#FIG3){ref-type="fig"}). The left eye shows regressed neovascularization, marked attenuation and sclerosis of the retinal arterial vasculature, and venous-venous collaterals (Figure [3b](#FIG3){ref-type="fig"}). 

Fluorescein angiography confirmed continued loss of foveal capillary architecture, greater in the right eye. Mild residual leakage from neovascularization in the right eye and late capillary leakage in the left eye were also noted (Figure [4a](#FIG4){ref-type="fig"} & Figure [4b](#FIG4){ref-type="fig"}). Spectral domain optical coherence tomography demonstrated only mild inner limiting membrane (ILM) changes in the left eye without secondary macular thickening. The retinal contour in both eyes was within normal limits.

Figure 4Fluorescein Angiography of Both Eyes 25 Months after PresentationFluorescein angiography 25 months after presentation confirmed the loss of foveal capillary architecture, greater in the right eye (Figure [4a](#FIG4){ref-type="fig"}). Persistent neovascularization is also present in the right eye (Figure [4a](#FIG4){ref-type="fig"}). Late capillary leakage from telengiectatic vessels is present in the left eye (Figure [4b](#FIG4){ref-type="fig"}).

At this time, 25-months post-presentation, a computed tomography (CT) angiogram of the thoracic aorta, great vessels, brain and neck vessels demonstrated a 70% stenosis of the right proximal external carotid artery, but otherwise, no significant stenosis was noted involving the carotid and vertebral systems. However, a 5 mm non-calcified, right middle lobe nodule along with mediastinal adenopathy was noted. Four months after his last visit to the eye clinic, that is 29 months after presentation, the patient was admitted to the hospital for dyspnea and congestive heart failure. During this admission, a repeat CT scan demonstrated worsening hilar adenopathy, and the patient underwent a hilar lymph node biopsy. Histopathologic examination confirmed the diagnosis of sarcoidosis.

Discussion
==========

Isolated posterior segment involvement is noted in only 5% of patients with sarcoid disease \[[@REF3]\]. The most common posterior findings are chorioretinitis and retinal periphlebitis with retinal hemorrhage. Roth spots, venous occlusions, and retinal neovascularization are atypical. In the largest series of sarcoid proliferative retinopathy patients, direct microvascular ischemia, rather than inflammation, has been proposed as the etiology of proliferative disease \[[@REF4]\]. Our experience supports this theory in that no signs of retinal phlebitis or ocular inflammation were noted at any time during his clinical course, with the patient's only retinal manifestations being progressive retinal vascular ischemia. Notably, ACE and lysozyme levels were negative. Both enzymes have limitations as neither predicts nor rules out sarcoidosis with absolute sensitivity or specificity \[[@REF5]-[@REF6]\].

Conclusions
===========

Ophthalmologists should be aware of the rare presentation of ocular sarcoidosis limited to retinal vascular ischemia and neovascularization.
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